To the Editor In a recent Viewpoint, Connor et al1 discussed diagnosis and risk classification in men with oligometastatic prostate cancer. They hypothesized that the diagnostic superiority of novel targeted imaging in detection of metastatic disease would allow early identification of oligometastatic prostate cancer, generating a stage migration and a so-called Will Rogers phenomenon for the survival of these patients.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fodor A, Picchio M, Di Muzio NG. Defining the Right State for a Will Rogers Phenomenon in Oligometastatic Prostate Cancer. JAMA Oncol. 2020;6(6):936–937. doi:10.1001/jamaoncol.2020.0574
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: